Oppenheimer & Co’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,700
Closed -$264K 1517
2021
Q2
$264K Sell
5,700
-3,000
-34% -$136K ﹤0.01% 1301
2021
Q1
$382K Buy
+8,700
New +$395K 0.01% 1077
2020
Q3
Sell
-6,385
Closed -$220K 1302
2020
Q2
$220K Buy
+6,385
New +$198K 0.01% 1078
2020
Q1
Sell
-11,885
Closed -$413K 1235
2019
Q4
$413K Buy
11,885
+970
+9% +$32.8K 0.01% 910
2019
Q3
$352K Buy
10,915
+2
+0% +$68 0.01% 930
2019
Q2
$374K Sell
10,913
-4,074
-27% -$137K 0.01% 924
2019
Q1
$502K Sell
14,987
-10,095
-40% -$318K 0.01% 823
2018
Q4
$692K Buy
25,082
+7,084
+39% +$220K 0.02% 633
2018
Q3
$691K Buy
17,998
+2,779
+18% +$102K 0.02% 732
2018
Q2
$534K Buy
15,219
+8,869
+140% +$309K 0.01% 838
2018
Q1
$212K Buy
+6,350
New +$216K 0.01% 1194

Other funds holding FFTY

Oppenheimer & Co's FFTY Position: Q3 2021 in Review

Oppenheimer & Co sold out of CapForce IBD 50 ETF (FFTY) in Q3 2021, closing a stake of 5,700 shares — an estimated $264K sold.

Oppenheimer & Co first reported a position in FFTY in Q1 2018 and held it in 11 quarters. The position peaked at $692K in Q4 2018. 70 funds tracked by Wall St. Rank hold FFTY as of Q3 2021.

  • Oppenheimer & Co reported no remaining CapForce IBD 50 ETF position as of Q3 2021 after selling out during the quarter.
  • Oppenheimer & Co sold 5,700 CapForce IBD 50 ETF shares in Q3 2021, an estimated $264K.
  • Oppenheimer & Co first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 11 quarters.
  • Oppenheimer & Co's CapForce IBD 50 ETF position peaked at $692K in Q4 2018.
  • 70 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2021.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.